
Achyut Healthcare Limited Approved Scheme for Amalgamation with Zenith Healthcare Limited
The Board of Directors of Achyut Healthcare Limited approved a Scheme of Amalgamation, in which the company would be absorbed into Zenith Healthcare Limited. The decision was taken at a board meeting held on July 14, 2026, following consideration of recommendations from the Audit Committee and the Committee of Independent Directors.Under the agreed-upon scheme, Achyut Healthcare Limited (the Transferor Company) will merge with Zenith Healthcare Limited (the Transferee Company). The amalgamation is planned to lead to the dissolution of Achyut without winding up. In consideration for the merger, which involves no cash payment, Zenith Healthcare Limited will issue fully paid-up Equity Shares of INR 1/- each to the equity shareholders of Achyut Healthcare Limited based on a determined Share Exchange Ratio.
Financial Status and Business Profile
The Scheme details provided information regarding both entities' financial health as of March 31, 2026. Achyut Healthcare Limited reported total assets of INR 3809.44 lakhs, with a net worth of INR 3506.12 lakhs. Its turnover (including other income) for the twelve months ended March 31, 2026, was INR 1197.15 lakhs.Zenith Healthcare Limited reported total assets of INR 1098.59 lakhs and a net worth of INR 742.42 lakhs as of March 31, 2026. Its turnover (including other income) for the same period was INR 1093.65 lakhs.
Key aspects of both companies include:
| Company | Business Area |
|---|---|
| Achyut Healthcare Limited | Trading and dealing in active pharmaceutical ingredients (APIs) and pharmaceutical products. It is also undertaking the installation and commissioning of GMP manufacturing facilities for various pharmaceutical products, including General Tablets, Effervescent Tablets, Capsules, Liquid Inhalation (Sevoflurane), and Sachet. |
| Zenith Healthcare Limited | Primarily engaged in the manufacturing, marketing, sale, and export of pharmaceuticals. |
Rationale for Amalgamation
The companies operate in similar or related businesses, and the proposed amalgamation aims to achieve increased revenues and enhance financial, operational, and organizational efficiency.Strategic benefits highlighted for the combined entity include:
- Enhancing the product portfolios and marketing capabilities of both companies to meet comprehensive consumer needs.
- Leveraging the brand value and manufacturing expertise of Zenith Healthcare Limited to create long-term value for Achyut's stakeholders.
- Optimizing manufacturing capacity across both facilities.
- Simplifying the group structure by reducing the number of entities in similar or related businesses within the group.
- Streamlining legal and regulatory compliance, leading to a reduction in overall compliance costs.
Transaction Details and Shareholding
The financial details confirm that no cash consideration is payable under the scheme. Shareholders of Achyut will receive Equity Shares of Zenith at a set rate.Share Exchange Ratio:
For every 50 fully paid-up Equity Shares of INR 1/- each of Achyut Healthcare Limited, the shareholders will be issued 119 fully paid-up Equity Shares of Zenith Healthcare Limited (INR 1/- each).
The scheme proposes a consequent change in the equity shareholding pattern within the Transferee Company. The following table illustrates the shift in ownership structure:
| Category | Pre Amalgamation Total Shares | Pre Amalgamation % Share Holding | Post Amalgamation Total Shares | Post Amalgamation % Share Holding |
|---|---|---|---|---|
| Promoter (Achyut) | 1,54,43,579 | 28.74% | 28,77,22,683 | 45.80% |
| Public Shareholders | 3,82,95,421 | 71.26% | 34,04,45,977 | 54.20% |
| Total | 5,37,39,000 | 100% | 62,81,68,660 | 100% |
The scheme is subject to requisite approvals and sanction from the National Company Law Tribunal (NCLT), as well as shareholder and/or creditor approval.
Stock Price Movement
At the close of trade on Tuesday, Achyut Healthcare Ltd. settled at ₹7.88, finishing down 0.25%. The shares saw significant intraday movement, trading within a range stretching from a low of ₹7.51 to a high of ₹8.24.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.